BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31782041)

  • 1. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
    Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
    Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and risk of renal cell carcinoma: differences by race.
    Hofmann JN; Corley DA; Zhao WK; Colt JS; Shuch B; Chow WH; Purdue MP
    Epidemiology; 2015 Jan; 26(1):59-67. PubMed ID: 25393631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.
    Cote ML; Colt JS; Schwartz KL; Wacholder S; Ruterbusch JJ; Davis F; Purdue M; Graubard BI; Chow WH
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):770-9. PubMed ID: 22426145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
    Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
    Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and risk of renal cell carcinoma among white and black Americans.
    Colt JS; Schwartz K; Graubard BI; Davis F; Ruterbusch J; DiGaetano R; Purdue M; Rothman N; Wacholder S; Chow WH
    Epidemiology; 2011 Nov; 22(6):797-804. PubMed ID: 21881515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States.
    Purdue MP; Colt JS; Graubard B; Davis F; Ruterbusch JJ; Digaetano R; Karami S; Wacholder S; Schwartz K; Chow WH
    Cancer Causes Control; 2011 Nov; 22(11):1537-44. PubMed ID: 21866373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
    Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
    Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
    Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
    Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
    Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
    Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black-White Differences in Ischemic Stroke Risk Factor Burden in Young Adults.
    Aradine EM; Ryan KA; Cronin CA; Wozniak MA; Cole JW; Chaturvedi S; Dutta TLM; Hou Y; Mehndiratta P; Motta M; Phipps MS; Yarbrough KL; McArdle PF; Kittner SJ
    Stroke; 2022 Mar; 53(3):e66-e69. PubMed ID: 34802251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
    Filson CP; Schwartz K; Colt JS; Ruterbusch J; Linehan WM; Chow WH; Miller DC
    Urol Oncol; 2014 Jan; 32(1):27.e15-21. PubMed ID: 23419677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation.
    Murphy KA; Jackson JW; Purnell TS; Shaffer AA; Haugen CE; Chu NM; Crews DC; Norman SP; Segev DL; McAdams-DeMarco MA
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):843-851. PubMed ID: 32381582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    Bancks MP; Kershaw K; Carson AP; Gordon-Larsen P; Schreiner PJ; Carnethon MR
    JAMA; 2017 Dec; 318(24):2457-2465. PubMed ID: 29279935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin and adiponectin levels and risk of renal cell carcinoma.
    Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP
    Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and renal cell cancer: the influence of race and sex.
    Beebe-Dimmer JL; Colt JS; Ruterbusch JJ; Keele GR; Purdue MP; Wacholder S; Graubard BI; Davis F; Chow WH; Schwartz KL
    Epidemiology; 2012 Nov; 23(6):821-8. PubMed ID: 23007040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity and renal cell carcinoma among black and white Americans: a case-control study.
    Xiao Q; Liao L; Matthews CE; Chow WH; Davis F; Schwartz K; Purdue M; Hofmann JN; Colt J
    BMC Cancer; 2014 Sep; 14():707. PubMed ID: 25253394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
    Duru OK; Li S; Jurkovitz C; Bakris G; Brown W; Chen SC; Collins A; Klag M; McCullough PA; McGill J; Narva A; Pergola P; Singh A; Norris K
    Am J Kidney Dis; 2008 Feb; 51(2):192-8. PubMed ID: 18215697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.
    Peres LC; Bethea TN; Camacho TF; Bandera EV; Beeghly-Fadiel A; Chyn DL; Harris HR; Joslin CE; Moorman PG; Myers E; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Rosenberg L; Schildkraut JM
    J Natl Cancer Inst; 2021 Jun; 113(6):710-718. PubMed ID: 33252629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.
    Rabbani F; Herr HW; Almahmeed T; Russo P
    J Clin Oncol; 2002 May; 20(9):2370-5. PubMed ID: 11981010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.